CHRISTINE SLACK: Open Payments
NPI 1457898876 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,702 in 113 payments from 36 companies in 2025. Trend: 2023 $0 · 2024 $131 · 2025 $2,702
Food & beverage: $2,603Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $407 |
| AstraZeneca Pharmaceuticals LP | 8 | $263 |
| Merck Sharp & Dohme LLC | 8 | $163 |
| Novocure Inc. | 1 | $143 |
| Novartis Pharmaceuticals Corporation | 7 | $127 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Incyte Corporation | 6 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $108 |
| Dendreon Pharmaceuticals LLC | 4 | $80 |
| SOBI, INC | 4 | $80 |
Products named: ERLEADA, Optune Lua (NovoTTF-200T), KEYTRUDA, AIRSUPRA, AUSTEDO XR, DARZALEX, KISQALI, PROVENGE.
Industry payments across MO — which companies pay providers there.
